Company news

HBM Holdings Ltd. news in 2026

HBM Holdings Ltd.'s news releases, calls and decks from 2026, newest first.

View company

Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026

November 5, 2026

Next Day Disclosure Return

November 4, 2026

Next Day Disclosure Return

November 3, 2026

Next Day Disclosure Return

November 2, 2026

Next Day Disclosure Return

October 30, 2026

Next Day Disclosure Return

October 27, 2026

Inside information announcement - NMPA approval of batoclimab injection (subcutaneous injection) for the treatment of generalized Myasthenia Gravis

October 22, 2026

Next Day Disclosure Return

October 20, 2026

Next Day Disclosure Return

October 16, 2026

Next Day Disclosure Return

October 15, 2026

Next Day Disclosure Return

October 14, 2026

Next Day Disclosure Return

October 13, 2026

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026

October 7, 2026

Supplemental announcement in relation to the 2025 annual report and the 2026 interim report

September 21, 2026

Voluntary announcement - nona biosciences develops the world's first language model trained on fully human heavy-chain-only antibodies

September 16, 2026

Harbour BioMed Announces U.S. FDA IND Clearance for HBM7004 for the Treatment of Advanced Solid Tumors

May 8, 2026

Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Atopic Dermatitis

March 9, 2026

Harbour BioMed Announces Positive Profit Alert for 2025 Annual Results

February 3, 2026

Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration

January 18, 2026

Control Devices Acquires Sherwood Valve

January 12, 2026

Decks in 2026